Gene therapy using a viral vector that delivers the human nerve growth factor (NGF) gene to the basal nucleus of Meinert has demonstrated high safety in patients with mild to moderate Alzheimer's disease, according to Pannochka, an online publication for ...
13 July 2022, 18:15 ()